Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Nicola Barclay-Prout
  • July 7, 2020
  • Blogs

Fighting talk

Fighting talk

One thing that grasps my interest is how society has adopted military style language when talking about cancer

Treatments are described as “defending” or “protecting” whilst cancer patients themselves are “fighters” who “battle” to “beat” the disease. These abstract metaphors of war are used in an attempt to articulate that cancer is a very emotional experience for all involved.
This terminology is intriguing to me, as whilst widely recognised as persuasive, it is also considered controversial.  War-like analogies suggest that there will be a “winner”, “loser”, and a “battlefield”. Sadly there are hundreds of types of cancer, and short of resection, there is no definitive cure for any of them. I have to ask myself, how do progressed metastatic patients feel anything other than failure when we talk about the disease in this way?

read more »

Excellence in oncology

Developing an effective biomarker strategy

Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients. Payers are able to demonstrate that the treatment they are paying for will be of maximum value. Physicians feel confident that they are offering an effective drug, which is at the cutting-edge of medicine. And patients clearly benefit from a treatment programme that reduces the risk of unnecessary toxicities and offers them better outcomes.

read more »

  • Posted by Marc Yates
  • December 17, 2014
  • Articles

Ageing in China: The Implications for Healthcare

Ageing in China: The Implications for Healthcare

Published in eyeforpharma 12 December by Marc Yates

China’s population has aged much faster than other populations, and this rapid ageing poses challenges to healthcare, among which the most common are a surging healthcare expenditure and a rising difficulty in managing the 'iron triangle'. China’s population has aged much faster than other populations, and the proportion of elderly among the total population is set to remain very high for years to come. The average time taken by developed countries for the percentage of the population above 65 years old to increase from 7% to 17% was 60 years, but China is expected to take only 30 years to reach the same level.  By 2050, the proportion of the population over 65 in China is projected to reach 34%, which is comparable with Denmark, and much higher than the US (26%). Increased longevity and lower fertility rate are typically the two main factors that contribute to an ageing population. In the case of China, the strict family planning policy (one-child policy) implemented in 1980 has played a key role in the country’s rapid shift in population structure. As each family is only allowed to have one child, China’s fertility rate has dropped sharply in the wake of the policy,…

read more »

  • Posted by Julie Denny
  • December 17, 2014
  • News

Supporting the babies of Forever Angels this holiday

Supporting the babies of Forever Angels this holiday

This year, we will be donating US$4500 to the charity Forever Angels

As in previous years, we are once again delighted to be making an annual contribution to our chosen charity, Forever Angels. This is based on a US$2,000 donation that we are making on behalf of our clients in lieu of Season's Greetings cards. In addition a further US$2,500 has been raised by our employees through various fund raising activities that have taken place across our global offices over the past year.

read more »

  • Posted by Katrina Johnson
  • December 16, 2014
  • Webinars

The patient journey: Time to look beyond the physician?

The patient journey: Time to look beyond the physician?

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

However a recent study demonstrated that physicians spend as little as 49 seconds in dealing with a new treatment initiation with their patients.
So it is no surprise that more and more pharma marketers are steadily looking beyond the physician in order to improve patient engagement.
In this webinar Director Katrina Johnson and Associate Director Kate Hanson explore the ways that patient journey research can aid development of an effective "beyond the pill" strategy, leading to greater patient engagement and improved treatment outcomes.

read more »